(VIANEWS) – The NASDAQ ended the session with FibroGen jumping 12.16% to $2.08 on Tuesday, following the last session’s upward trend. NASDAQ rose 0.37% to $16,035.30, after two consecutive sessions in a row of losses, on what was a somewhat up trend trading session today. FibroGen’s last close was $1.85, 92.14% below its 52-week high…
(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Viking Therapeutics, Vroom, and NASDAQ TEST STOCK. Rank Financial Asset Price Change Updated (EST) 1 Viking Therapeutics (VKTX) 86.01 123.53% 2024-02-27 15:17:38 2 Vroom (VRM)…
(VIANEWS) – FibroGen shares surge 15.14% and break the downward trend on NASDAQ. At 12:23 EST on Tuesday, shares of FibroGen (NASDAQ: FGEN) saw an astonishing 15.141% surge to EUR2.13, continuing their upward trend from Monday. This provided investors with some relief after two consecutive days of losses on NASDAQ, which now sits 0.27% up…
(VIANEWS) – FibroGen stock fell 14.16% to EUR1.88 at 12:24 EST Tuesday after experiencing an upward trend session, while NASDAQ also dropped 1.55% during an overall downward trend session, suggesting an overall negative trading session today. FibroGen closed with an inexact closing price of EUR2.19 which is 90.69% below its 52-week high of EUR23.53. About…
(VIANEWS) – The NASDAQ ended the session with FibroGen (FGEN) rising 14.69% to $2.73 on Friday while NASDAQ jumped 1.25% to $15,990.66. FibroGen’s last close was $2.38, 90.73% under its 52-week high of $25.68. About FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product…
(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Verb Technology Company, VerifyMe, and NASDAQ TEST STOCK. Rank Financial Asset Price Change Updated (EST) 1 Verb Technology Company (VERBW) 0.01 296.67% 2024-02-09 04:44:06 2…
(VIANEWS) – The NASDAQ ended the session with FibroGen jumping 10.14% to $2.39 on Thursday, following the last session’s upward trend. NASDAQ rose 0.24% to $15,793.71, after two successive sessions in a row of gains, on what was a somewhat positive trend exchanging session today. FibroGen’s last close was $2.17, 91.55% under its 52-week high…
(VIANEWS) – FibroGen Shares Experience 12.44% Surge on NASDAQ, Building upon Recent Gains Shares of FibroGen (NASDAQ: FGEN) surged 12.44% higher to EUR2.44 at 12:57 EST Thursday morning, continuing their gains from previous sessions and taking them a step further with two consecutive upward trends on NASDAQ that has now gained 0.19% to EUR15,787.27; continuing…
(VIANEWS) – FibroGen stock price experienced an 14.14% surge on Wednesday, rebounding from Tuesday’s decline by rising 14.14% to EUR2.18. NASDAQ is up 0.81% but FibroGen’s stock is 92.56% below its 52-week high of EUR25.68. About FibroGen FibroGen Pharmaceuticals Inc is a biopharmaceutical company with the mission of discovering, developing and commercializing therapeutics to address…
(VIANEWS) – At 11:10 EST on Friday morning, FibroGen (NASDAQ: FGEN) shares were down 13.5% to EUR2.05, following five straight sessions of increases. Still, the overall NASDAQ was up by 0.73% at EUR15,473.61, suggesting an overall upward trend. FibroGen had closed at EUR2.37 last week – 90.77% lower than its 52-week high of EUR25.69. About…
